Szende B, Fox M, Fox B W
Br J Cancer. 1973 Mar;27(3):245-52. doi: 10.1038/bjc.1973.29.
Cells of the methylene dimethanesulphonate-(MDMS)-resistant Yoshida sarcoma cell line contain a low molecular weight "resistance factor" which is present in the culture medium of these cells and may be utilized by MDMS-sensitive Yoshida sarcoma cells either by co-culturing the two cell lines or by culturing the MDMS-sensitive Yoshida cells in a medium containing 20% used medium of MDMS-resistant Yoshida cells or in the presence of dialysed medium from resistant cells. The "resistance factor" does not inactivate the drug itself or its metabolites, and it has no influence on the sensitivity of the cells if added after MDMS treatment. Twenty-four hours seems to be enough time for the transfer of the resistance factor, but its effect on whole populations decreases within 24 hours of ceasing the supply. The relationship between these findings and the known phenomena of metabolic co-operation are discussed.
对亚甲基二甲基磺酸盐(MDMS)具有抗性的吉田肉瘤细胞系的细胞含有一种低分子量的“抗性因子”,该因子存在于这些细胞的培养基中,并且可以通过将两种细胞系共培养,或者通过在含有20%抗性吉田细胞的用过的培养基的培养基中培养MDMS敏感的吉田细胞,或者在存在来自抗性细胞的透析培养基的情况下,被MDMS敏感的吉田肉瘤细胞利用。“抗性因子”不会使药物本身或其代谢产物失活,并且如果在MDMS处理后添加,对细胞的敏感性没有影响。24小时似乎足以完成抗性因子的转移,但其对整个群体的影响在停止供应后24小时内会降低。本文讨论了这些发现与已知的代谢合作现象之间的关系。